The main reason why many companies use mammalian cells instead of bacterial systems for the manufacture of recombinant proteins is due to the necessity of consistent protein refolding with retained bioactivity. We can achieve this is many models using E.coli systems that grow 20-25x faster than mammalian cell systems.